keyword
https://read.qxmd.com/read/38655259/effects-of-statins-beyond-lipid-lowering-agents-in-art-treated-hiv-infection
#1
REVIEW
Vikram Mehraj, Jun Chen, Jean-Pierre Routy
Antiretroviral therapies (ART) have reduced human immunodeficiency virus (HIV) infection-associated morbidity and mortality improving the life of people with HIV (PWH). However, ART lead to residual HIV production, which in conjunction with microbial translocation and immune dysfunction contributes to chronic inflammation and immune activation. PWH on ART remain at an increased risk for cardiovascular diseases (CVDs) including myocardial infarction and stroke; which in part is explained by chronic inflammation and immune activation...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38655185/statins-use-amidst-the-pandemic-prescribing-dispensing-adherence-persistence-and-correlation-with-covid-19-statistics-in-nationwide-real-world-data-from-poland
#2
JOURNAL ARTICLE
Przemysław Kardas, Angelika Kwiatek, Piotr Włodarczyk, Filip Urbański, Beata Ciabiada-Bryła
BACKGROUND: Adherence to medications presents a significant challenge in healthcare. Statins, used in primary and secondary prevention of cardiovascular disease, are of particular importance for public health. The outbreak of the COVID-19 pandemic resulted in additional healthcare system-related barriers impeding the execution of therapies. This study aimed to assess the use of as well as adherence and persistence to statins in a national cohort of 38 million of Polish citizens during pandemic...
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38653249/gene-specific-somatic-epigenetic-mosaicism-of-fdft1-underlies-a-non-hereditary-localized-form-of-porokeratosis
#3
JOURNAL ARTICLE
Sonoko Saito, Yuki Saito, Showbu Sato, Satomi Aoki, Harumi Fujita, Yoshihiro Ito, Noriko Ono, Takeru Funakoshi, Tomoko Kawai, Hisato Suzuki, Takashi Sasaki, Tomoyo Tanaka, Masukazu Inoie, Kenichiro Hata, Keisuke Kataoka, Kenjiro Kosaki, Masayuki Amagai, Kazuhiko Nakabayashi, Akiharu Kubo
Porokeratosis is a clonal keratinization disorder characterized by solitary, linearly arranged, or generally distributed multiple skin lesions. Previous studies showed that genetic alterations in MVK, PMVK, MVD, or FDPS-genes in the mevalonate pathway-cause hereditary porokeratosis, with skin lesions harboring germline and lesion-specific somatic variants on opposite alleles. Here, we identified non-hereditary porokeratosis associated with epigenetic silencing of FDFT1, another gene in the mevalonate pathway...
April 10, 2024: American Journal of Human Genetics
https://read.qxmd.com/read/38651770/statin-initiation-after-myocardial-infarction-in-patients-with-alcohol-related-liver-disease-a-nationwide-population-based-study
#4
JOURNAL ARTICLE
Axel Wester, Peter Jepsen, Hannes Hagström
BACKGROUND AND AIMS: Secondary prevention with statins improves clinical outcomes after myocardial infarction (MI). We aimed to compare odds of statin initiation after MI in patients with co-existing alcohol-related liver disease (ALD) to the general population, and the association between statin initiation and mortality in the patients with ALD. METHODS: All statin-naïve patients with ALD and a first-time MI between 2006 and 2020 were identified from Swedish healthcare registers and matched for age, sex, and year of MI with up to ten ALD-free general population controls with a first-time MI...
April 23, 2024: Liver International: Official Journal of the International Association for the Study of the Liver
https://read.qxmd.com/read/38651149/drug-repositioning-and-ovarian-cancer-a-study-based-on-mendelian-randomisation-analysis
#5
JOURNAL ARTICLE
Lin Zhu, Hairong Zhang, Xiaoyu Zhang, Ruoqing Chen, Lei Xia
BACKGROUND: The role of drug repositioning in the treatment of ovarian cancer has received increasing attention. Although promising results have been achieved, there are also major controversies. METHODS: In this study, we conducted a drug-target Mendelian randomisation (MR) analysis to systematically investigate the reported effects and relevance of traditional drugs in the treatment of ovarian cancer. The inverse-variance weighted (IVW) method was used in the main analysis to estimate the causal effect...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38651067/association-between-statin-use-and-acute-pulmonary-embolism-in-intensive-care-unit-patients-with-sepsis-a-retrospective-cohort-study
#6
JOURNAL ARTICLE
Dengcang Yang, Yanyan He, Qianqian Wang, Yi Yu
INTRODUCTION: Acute pulmonary embolism (APE) is a life-threatening medical condition that is frequently encountered and associated with significant incidence and mortality rates, posing a substantial threat to patients' well-being and quality of life. Sepsis is prominent independent risk factor for the development of APE. Despite recent investigations indicating a reduced APE risk through statin therapy, its impact on patients with sepsis and APE remains unresolved. METHODS: The Medical Information Mart for Intensive Care (MIMIC)-IV database was utilized to identify patients diagnosed with sepsis and APE, irrespective of statin treatment status, as part of this study...
2024: Frontiers in Medicine
https://read.qxmd.com/read/38649158/a-retrospective-study-on-the-efficacy-of-roxadustat-in-peritoneal-dialysis-patients-with-erythropoietin-hyporesponsiveness
#7
JOURNAL ARTICLE
Jie Liu, Shuang Li, Fan Yang, Tianyu Li, Rui Li, Yousuf Waheed, Chen Meng, Shulin Li, Kun Liu, Yanshan Tong, Haisheng Xu, Chuankuo Tian, Xinglei Zhou
BACKGROUND/AIMS: Roxadustat, an oral medication for treating renal anemia, is a hypoxia-inducible factor prolyl hydroxylase inhibitor used for regulating iron metabolism and promoting erythropoiesis. To investigate the efficacy and safety of roxadustat in patients undergoing peritoneal dialysis (PD) with erythropoietin hyporesponsiveness. METHODS: Single-center, retrospective study, 81 PD patients (with erythropoietin hyporesponsiveness) were divided into the roxadustat group (n = 61) and erythropoiesis-stimulating agents (ESAs) group (n = 20)...
April 23, 2024: Korean Journal of Internal Medicine
https://read.qxmd.com/read/38648584/wound-healing-cellular-review-with-specific-attention-to-postamputation-care
#8
JOURNAL ARTICLE
David S Kirwin, Harrison E Diaz, Travis C Frantz, Cory F Janney, Curtis L Hardy, W Hugh Lyford
Wound healing is crucial for survival, prevention of infection, and restoration of tissue function. The immune system drives this process with 3 main phases: inflammation, proliferation, and remodeling. Keloids and hypertrophic scars reveal disruptions in these phases, underscoring the balance needed for healing. Limb amputation, a life-changing event, demands careful consideration for healing and function. Factors such as amputation level, surgical technique, and prosthetic fitting shape outcomes, while complications such as heterotopic ossification challenge recovery...
March 2024: Cutis; Cutaneous Medicine for the Practitioner
https://read.qxmd.com/read/38648228/assessing-the-causal-associations-of-different-types-of-statins-use-and-knee-hip-osteoarthritis-a-mendelian-randomization-study
#9
JOURNAL ARTICLE
Xin Chen, Xin Huang, Youqun Liu, Zhiwei Zhang, Jiliang Chen
OBJECTIVE: This study comprehensively evaluated the causal relationship between different types of statins use and knee/hip osteoarthritis (OA) using a two-sample and multivariate Mendelian randomization (MR) method. METHODS: MR analysis was conducted using publicly available summary statistics data from genome-wide association studies (GWAS) to assess the causal associations between total statins use (including specific types) and knee/hip OA. The primary analysis utilized the inverse variance-weighted (IVW) method, with sensitivity analysis conducted to assess robustness...
2024: PloS One
https://read.qxmd.com/read/38645743/baseline-perihematomal-edema-c-reactive-protein-and-30-day-mortality-are-not-associated-in-intracerebral-hemorrhage
#10
JOURNAL ARTICLE
Oluwaseun A Sobowale, Isabel C Hostettler, Teddy Y Wu, Calvin Heal, Duncan Wilson, Darshan G Shah, Daniel Strbian, Jukka Putaala, Turgut Tatlisumak, Andy Vail, Gagan Sharma, Stephen M Davis, David J Werring, Atte Meretoja, Stuart M Allan, Adrian R Parry-Jones
BACKGROUND: The relationship between baseline perihematomal edema (PHE) and inflammation, and their impact on survival after intracerebral hemorrhage (ICH) are not well understood. OBJECTIVE: Assess the association between baseline PHE, baseline C-reactive protein (CRP), and early death after ICH. METHODS: Analysis of pooled data from multicenter ICH registries. We included patients presenting within 24 h of symptom onset, using multifactorial linear regression model to assess the association between CRP and edema extension distance (EED), and a multifactorial Cox regression model to assess the association between CRP, PHE volume and 30-day mortality...
2024: Frontiers in Neurology
https://read.qxmd.com/read/38645437/molecular-mechanism-and-intervention-measures-of-microvascular-complications-in-diabetes
#11
REVIEW
Rui Xu, Ziming Fang, Hongyu Wang, Ye Gu, Liying Yu, Boyang Zhang, Jingyu Xu
OBJECTIVE: In this article, the epidemiology, molecular mechanism of occurrence and development, risk factors, and treatment of diabetic microvascular complications such as diabetic nephropathy, diabetic retinopathy, and diabetic peripheral neuropathy were discussed, providing the theoretical basis for more accurate elucidation of the pathogenesis and treatment of diabetic microvascular complications. METHODS: The electronic database of PubMed was searched, and retrieved papers were screened for eligibility by two independent reviewers...
2024: Open Medicine (Warsaw, Poland)
https://read.qxmd.com/read/38643042/cardio-protective-effects-of-statins-in-patients-undergoing-anthracycline-based-chemotherapy-an-updated-meta-analysis-of-randomized-controlled-trials
#12
JOURNAL ARTICLE
Nicole Felix, Paula C Nogueira, Isadora M Silva, Thomaz Alexandre Costa, Carlos Alberto Campello, Carlos Stecca, Renato D Lopes
INTRODUCTION: Several interventions have been tested for cardio-protection against anthracycline-induced cancer therapy-related cardiovascular dysfunction (CTRCD). The role of statins in this setting remains unclear. METHODS: We systematically searched PubMed, Embase, Cochrane Library, Clinicaltrials.gov, and Web of Science for randomized controlled trials (RCTs) comparing statins versus control (placebo or no intervention) for preventing anthracycline-induced CTRCD...
April 19, 2024: European Journal of Internal Medicine
https://read.qxmd.com/read/38643002/are-there-lost-opportunities-in-chronic-kidney-disease-a-region-wide-cohort-study
#13
JOURNAL ARTICLE
Johan Sundström, Anna Norhammar, Stelios Karayiannides, Johan Bodegård, Stefan Gustafsson, Thomas Cars, Maria Eriksson Svensson, Johan Ärnlöv
OBJECTIVES: Identify the windows of opportunity for the diagnosis of chronic kidney disease (CKD) and the prevention of its adverse outcomes and quantify the potential population gains of such prevention. DESIGN AND SETTING: Observational, population-wide study of residents in the Stockholm and Skåne regions of Sweden between 1 January 2015 and 31 December 2020. PARTICIPANTS: All patients who did not yet have a diagnosis of CKD in healthcare but had CKD according to laboratory measurements of CKD biomarkers available in electronic health records...
April 19, 2024: BMJ Open
https://read.qxmd.com/read/38641905/hydroxymethylglutaryl-coa-reductase-activity-is-essential-for-mitochondrial-%C3%AE-oxidation-of-fatty-acids-to-prevent-lethal-accumulation-of-long-chain-acylcarnitines-in-the-mouse-liver
#14
JOURNAL ARTICLE
Edgars Liepinsh, Liga Zvejniece, Laura Clemensson, Melita Ozola, Edijs Vavers, Helena Cirule, Stanislava Korzh, Sandra Skuja, Valerija Groma, Monta Briviba, Solveiga Grinberga, Wen Liu, Paweł Olszewski, Mélissa Gentreau, Robert Fredriksson, Maija Dambrova, Helgi B Schiöth
BACKGROUND AND PURPOSE: Statins are competitive inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase (HMGCR), and exert adverse effects on mitochondrial function, although the mechanisms underlying these effects remain unclear. We used a tamoxifen-induced Hmgcr-knockout (KO) mouse model, a multi-omics approach and mitochondrial function assessments to investigate whether decreased HMGCR activity impacts key liver energy metabolism pathways. EXPERIMENTAL APPROACH: We established a new mouse strain using the Cre/loxP system, which enabled whole-body deletion of Hmgcr expression...
April 19, 2024: British Journal of Pharmacology
https://read.qxmd.com/read/38640433/current-treatments-for-the-management-of-homozygous-familial-hypercholesterolemia-a-systematic-review-and-commentary
#15
JOURNAL ARTICLE
Jing Gu, Rupal N Gupta, Henry Cheng, Yingxin Xu, Frederick J Raal
AIMS: Homozygous familial hypercholesterolemia (HoFH) is a rare disorder characterized by markedly elevated circulating low-density lipoprotein cholesterol (LDL-C) from birth. This review aimed to critically evaluate treatments for HoFH with respect to their efficacy, safety, accessibility, overall context and position within the treatment pathway. METHODS: A mixed-methods review was undertaken to systematically identify and characterize primary interventional studies on HoFH, with a focus on LDL-C reduction as the primary outcome...
April 18, 2024: European Journal of Preventive Cardiology
https://read.qxmd.com/read/38640337/role-and-molecular-mechanism-of-salvia-miltiorrhiza-associated-with-chemical-compounds-in-the-treatment-of-diabetes-mellitus-and-its-complications-a-review
#16
JOURNAL ARTICLE
Jiajie Li, Jinxing Liu, Weibing Shi, Jinchen Guo
Diabetes mellitus (DM) is one of the most prevalent diseases worldwide, greatly impacting patients' quality of life. This article reviews the progress in Salvia miltiorrhiza, an ancient Chinese plant, for the treatment of DM and its associated complications. Extensive studies have been conducted on the chemical composition and pharmacological effects of S miltiorrhiza, including its anti-inflammatory and antioxidant activities. It has demonstrated potential in preventing and treating diabetes and its consequences by improving peripheral nerve function and increasing retinal thickness in diabetic individuals...
April 19, 2024: Medicine (Baltimore)
https://read.qxmd.com/read/38639527/dyslipidemia-and-heart-failure-current-evidence-and-perspectives-of-use-of-statins
#17
JOURNAL ARTICLE
A Pradhan, M Bhandari, P Vishwakarma, P Gualtieri, L Di Renzo, F Iellamo, R Sethi, M A Perrone
Heart failure (HF) is a condition with growing morbidity and mortality. Dyslipidemia in HF is not concentrated around hypercholesterolemia as in coronary artery disease. As a corollary, the robust benefits seen with statins across the spectrum of CAD have not been replicated in HF. Multiple potential pleiotropic effects of statins include anti-inflammatory, antioxidant, endothelial stabilization, antiapoptotic, anti-thrombotic, and modulation of the autonomic system apart from lipid lowering. These benevolent actions need to be counterbalanced with the potential derangement of ubiquinone, selenoprotein and endotoxin pathways...
April 2024: European Review for Medical and Pharmacological Sciences
https://read.qxmd.com/read/38639436/atorvastatin-induced-intracerebral-hemorrhage-is-inhibited-by-berberine-in-zebrafish
#18
JOURNAL ARTICLE
Xin-Yan Liu, Bo Chen, Rui Zhang, Miao-Qing Zhang, Yuan-Yuan Ma, Ying Han, Jian-Dong Jiang, Jing-Pu Zhang
Intracerebral hemorrhage (ICH), for which there are currently no effective preventive or treatment methods, has a very high fatality rate. Statins, such as atorvastatin (ATV), are the first-line drugs for regulating blood lipids and treating hyperlipidemia-related cardiovascular diseases. However, ATV-associated ICH has been reported, although its incidence is rare. In this study, we aimed to investigate the protective action and mechanisms of berberine (BBR) against ATV-induced brain hemorrhage. We established an ICH model in zebrafish induced by ATV (2 μM) and demonstrated the effects of BBR (10, 50, and 100 μM) on ICH via protecting the vascular network using hemocyte staining and three transgenic zebrafish...
April 19, 2024: Journal of Applied Toxicology: JAT
https://read.qxmd.com/read/38639378/european-and-us-guideline-based-statin-eligibility-genetically-predicted-coronary-artery-disease-and-the-risk-of-major-coronary-events
#19
JOURNAL ARTICLE
Hanjin Park, Daehoon Kim, Seng Chan You, Eunsun Jang, Hee Tae Yu, Tae-Hoon Kim, Dong-Min Kim, Jung-Hoon Sung, Hui-Nam Pak, Moon-Hyoung Lee, Pil-Sung Yang, Boyoung Joung
BACKGROUND: A study was designed to investigate whether the coronary artery disease polygenic risk score (CAD-PRS) may guide lipid-lowering treatment initiation as well as deferral in primary prevention beyond established clinical risk scores. METHODS AND RESULTS: Participants were 311 799 individuals from the UK Biobank free of atherosclerotic cardiovascular disease, diabetes, chronic kidney disease, and lipid-lowering treatment at baseline. Participants were categorized as statin indicated, statin indication unclear, or statin not indicated as defined by the European and US guidelines on statin use...
April 19, 2024: Journal of the American Heart Association
https://read.qxmd.com/read/38639369/secondary-prevention-in-patients-with-stroke-versus-myocardial-infarction-analysis-of-2-national-cohorts
#20
JOURNAL ARTICLE
Cyprien A Rivier, Julian N Acosta, Audrey C Leasure, Rachel Forman, Richa Sharma, Adam de Havenon, Erica S Spatz, Silvio E Inzucchi, Walter N Kernan, Guido J Falcone, Kevin N Sheth
BACKGROUND: The implementation of preventive therapies among patients with stroke remains inadequately explored, especially when compared with patients with myocardial infarction (MI), despite sharing similar vascular risk profiles. We tested the hypothesis that participants with a history of stroke have a worse cardiovascular prevention profile in comparison to participants with MI. METHODS AND RESULTS: In cross-sectional analyses within the UK Biobank and All of Us Research Program, involving 14 760 (9193 strokes, 5567 MIs) and 7315 (2948 strokes, 4367 MIs) participants, respectively, we evaluated cardiovascular prevention profiles assessing low-density lipoprotein (<100 mg/dL), blood pressure (systolic, <140 mm Hg; and diastolic, <90 mm Hg), statin and antiplatelet use, and a cardiovascular prevention score that required meeting at least 3 of these criteria...
April 19, 2024: Journal of the American Heart Association
keyword
keyword
533
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.